Sign in

CIK 0001870144 · <br>Emerging growth company

Cardio Diagnostics Holdings, Inc.

Sign in to watch
Ticker
CDIO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870925574
Phone
855-226-9991
Business address
311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
Former names
Mana Capital Acquisition Corp.

Securities

  • CDIO Common stock Nasdaq
  • CDIOW Warrant Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Option exercise Director acquired 917 shares (option exercise)
  3. 3 Insider Initial Statement of Ownership
  4. 4/A Option exercise Director acquired 5,020 shares (option exercise)
  5. 4 Option exercise Director acquired 5,020 shares (option exercise)
  6. 4 Option exercise Director acquired 5,020 shares (option exercise)
  7. 4 Option exercise Director acquired 5,020 shares (option exercise)
  8. 4 Option exercise Director acquired 6,626 shares (option exercise)
  9. 4 Option exercise Director acquired 6,631 shares (option exercise)
  10. 4/A Derivatives Options or other derivatives
  11. 4 Option exercise Director acquired 47,937 shares (option exercise)
  12. 4/A Option exercise Director acquired 36,765 shares (option exercise)
  13. 4/A Option exercise Director acquired 36,765 shares (option exercise)
  14. 4/A Option exercise Director acquired 36,765 shares (option exercise)
  15. 4 Option exercise Director acquired 36,765 shares (option exercise)
  16. 4 Option exercise Director acquired 36,765 shares (option exercise)
  17. 4 Option exercise Director acquired 36,765 shares (option exercise)
  18. 4 Open-market buy Chief Executive Officer bought 18,251 shares at an average $0.55 ($9,964)
  19. 4 Open-market buy Chief Technology Officer bought 18,251 shares at an average $0.55 ($9,964)
  20. 4 Open-market buy Chief Medical Officer bought 34,000 shares at an average $0.60 ($20,395)

Page 4 of 6 · 113 filings